Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kimmelman

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Nature Reviews. Clinical Oncology|September 1, 2019
Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicineJonathan Kimmelman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
Ethics at phase 0: clarifying the issuesJonathan Kimmelman
Clinical Trials (London, England)|August 16, 2024
Commentary on Astrachan et al. The transmutation of research risk in pragmatic clinical trialsJonathan Kimmelman
Handbook of Clinical Neurology|September 28, 2024
Ethics of gene and cell therapy development for neurologic disordersJonathan Kimmelman
Bioethics|January 19, 2011
Ethics, ambiguity aversion, and the review of complex translational clinical trialsJonathan Kimmelman
BMJ (Clinical Research Ed.)|January 8, 2005
Recent developments in gene transfer: risk and ethicsJonathan Kimmelman
Retina (Philadelphia, Pa.)|November 30, 2007
Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degenerationJonathan Kimmelman
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2009
Tomorrow, interrupted? Risk, ethics, and medical advance in gene transferJonathan Kimmelman
IRB|October 14, 2005
Medical research, risk, and bystandersJonathan Kimmelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Is Participation in Cancer Phase I Trials Really Therapeutic?Jonathan Kimmelman
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Nature Reviews. Clinical Oncology|September 1, 2019
Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicineJonathan Kimmelman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
Ethics at phase 0: clarifying the issuesJonathan Kimmelman
Clinical Trials (London, England)|August 16, 2024
Commentary on Astrachan et al. The transmutation of research risk in pragmatic clinical trialsJonathan Kimmelman
Handbook of Clinical Neurology|September 28, 2024
Ethics of gene and cell therapy development for neurologic disordersJonathan Kimmelman
Bioethics|January 19, 2011
Ethics, ambiguity aversion, and the review of complex translational clinical trialsJonathan Kimmelman
BMJ (Clinical Research Ed.)|January 8, 2005
Recent developments in gene transfer: risk and ethicsJonathan Kimmelman
Retina (Philadelphia, Pa.)|November 30, 2007
Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degenerationJonathan Kimmelman
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2009
Tomorrow, interrupted? Risk, ethics, and medical advance in gene transferJonathan Kimmelman
IRB|October 14, 2005
Medical research, risk, and bystandersJonathan Kimmelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Is Participation in Cancer Phase I Trials Really Therapeutic?Jonathan Kimmelman
Pageof 20